Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
63.10
+2.28 (3.75%)
At close: Dec 11, 2025, 4:00 PM EST
63.72
+0.62 (0.98%)
Pre-market: Dec 12, 2025, 4:10 AM EST
Lantheus Holdings Revenue
Lantheus Holdings had revenue of $384.01M in the quarter ending September 30, 2025, with 1.39% growth. This brings the company's revenue in the last twelve months to $1.53B, up 1.95% year-over-year. In the year 2024, Lantheus Holdings had annual revenue of $1.53B with 18.32% growth.
Revenue (ttm)
$1.53B
Revenue Growth
+1.95%
P/S Ratio
2.83
Revenue / Employee
$1,888,531
Employees
808
Market Cap
4.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.53B | 237.48M | 18.32% |
| Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
| Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
| Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
| Dec 31, 2020 | 339.41M | -7.93M | -2.28% |
| Dec 31, 2019 | 347.34M | 3.96M | 1.15% |
| Dec 31, 2018 | 343.37M | 12.00M | 3.62% |
| Dec 31, 2017 | 331.38M | 29.53M | 9.78% |
| Dec 31, 2016 | 301.85M | 8.39M | 2.86% |
| Dec 31, 2015 | 293.46M | -8.14M | -2.70% |
| Dec 31, 2014 | 301.60M | 17.93M | 6.32% |
| Dec 31, 2013 | 283.67M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LNTH News
- 4 days ago - Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH) - Newsfile Corp
- 4 weeks ago - The Bottom Fishing Club - Lantheus Holdings: Interesting Buy Momentum Supporting Price - Seeking Alpha
- 4 weeks ago - Carillon Eagle Small Cap Growth Fund Q3 2025 Portfolio Update - Seeking Alpha
- 4 weeks ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus - Newsfile Corp
- 5 weeks ago - Lantheus Holdings, Inc. (LNTH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - LNTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus - GlobeNewsWire
- 6 weeks ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit – LNTH - GlobeNewsWire